XIST and breast cancer: As expected, immunohistochemistry (IHC) and RNA in situ hybridization analyses demonstrated that pAKT levels were higher in Xist-negative breast cancer tissue, while Xist-positive samples yielded lower pAKT levels (Figure 3A), suggesting an inverse correlation between Xist and pAKT levels.